Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome.
Antonios Douros, MD, Department of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany, Tel.: +49 30 450 525 225, Fax: +49 40 450 7 525 112, E-mail: antonios.douros@charite.de.
A
A
Douros
L
L
Schlemm
J
J
Bolbrinker
M
M
Ebinger
R
R
Kreutz
D000284:Administration, Oral; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics; D001281:Atrial Fibrillation / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics; D001682:Biological Availability; D001777:Blood Coagulation / Q000187:drug effects*; D000069604:Dabigatran; D016903:Drug Monitoring; D057915:Drug Substitution; D065427:Factor Xa Inhibitors / Q000008:administration & dosage; D005260:Female; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control; D007408:Intestinal Absorption; D009025:Morpholines / Q000008:administration & dosage; D011237:Predictive Value of Tests; D011725:Pyridines / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics; D012307:Risk Factors; D000069552:Rivaroxaban; D012778:Short Bowel Syndrome / Q000150:complications* / Q000378:metabolism; D013876:Thiophenes / Q000008:administration & dosage; D016896:Treatment Outcome
D000925:Anticoagulants; D001562:Benzimidazoles; D065427:Factor Xa Inhibitors; D009025:Morpholines; D011725:Pyridines; D013876:Thiophenes; D000069552:Rivaroxaban; D000069604:Dabigatran